KZR vs MRNA · $53.9M cap vs rev $145.0M
Kezar Life Sciences Inc (KZR) versus Moderna Inc (MRNA) — a side-by-side from cached financials, not a winner call.
Kezar Life Sciences Inc (KZR) is a biotechnology company listed on NASDAQ.
Moderna Inc (MRNA) is a biotechnology company listed on NASDAQ. It is led by Stéphane Bancel M.B.A..
Latest reported KZR revenue for 2024-12-31 was $0. Net income was -$83.7M. Revenue was down 100.0% from 2023-12-31 to 2024-12-31. KZR currently screens at market cap $53.9M.
Latest reported MRNA revenue for 2026-06-30 was $145.0M. Net income was -$782.0M. Revenue was down 62.7% from 2026-03-31 to 2026-06-30. MRNA currently screens at market cap $24.52B.
KZR currently screens at market cap $53.9M. MRNA currently screens at market cap $24.52B.
Not investment advice. Open the KZR and MRNA stock pages for the full models.
Not investment advice.